IP Library Granted Patent US 7,935,515
Granted Patent B2
US 7,935,515 · App. 12/628,150 · Granted May 3, 2011

Recombinant microalgae cells producing novel oils

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,935,515
App. No.
12/628,150
Granted
May 3, 2011
Kind
B2
Abstract

Disclosed herein are obligate heterotrophic microalgae cells containing an exogenous gene. In some embodiments the gene is a sucrose utilization gene, and further disclosed are methods of manufacturing triglyceride oils using sugar cane or sugar beets as a feedstock in a heterotrophic fermentation. In other embodiments the feedstock is depolymerized cellulosic material. Also disclosed are cells that produce medium chain fatty acids at levels not produced in non-recombinant cells of the same species and genus.

Claims (22)

1. A cell of the genus Prototheca comprising one or more exogenous gene, wherein the exogenous gene is a sucrose invertase gene, a fatty acyl-ACP (acyl carrier protein) thioesterase gene, a fatty acyl-CoA/aldehyde reductase gene, a fatty acyl-CoA reductase gene or a fatty aldehyde decarbonylase gene and is integrated into a nuclear chromosome of the cell, and wherein the sucrose invertase gene encodes a sucrose invertase having a catalytic activity of hydrolyzing sucrose to glucose and fructose, the fatty acyl-ACP thioesterase gene encodes a fatty acyl-ACP thioesterase having a catalytic activity of hydrolyzing a fatty acyl-ACP substrate, the fatty acyl-CoA/aldehyde reductase gene encodes a fatty acyl-CoA/aldehyde reductase having a catalytic activity of reducing a fatty acyl-CoA molecule to a primary alcohol, the fatty acyl-CoA reductase gene encodes a fatty acyl-CoA reductase having a catalytic activity of reducing a fatty acyl-CoA molecule to an aldehyde, and the fatty aldehyde decarbonylase gene encodes a fatty aldehyde decarbonylase having a catalytic activity of converting a fatty aldehyde to an alkane or alkene.

2. The cell of claim 1 , wherein the coding sequence of the exogenous gene is in operable linkage with a promoter from a gene endogenous to a species of the genus Prototheca.

3. The cell of claim 2 , wherein the promoter is upregulated at least 3-fold in a cell of the genus Prototheca when the extracellular environment changes from containing at least 5 mM nitrogen to containing no nitrogen.

4. The cell of claim 1 , wherein the exogenous gene encodes a fatty acyl-ACP thioesterase that has hydrolysis activity towards one or more fatty acyl-ACP substrates of chain length C8, C10, C12 or C14.

5. The cell of claim 4 , wherein the fatty acyl-ACP thioesterase has an amino acid sequence comprising any of SEQ ID NOs: 59, 61, 63 and 138-140.

6. The cell of claim 4 , wherein the coding sequence comprises a plastid targeting sequence selected from one or more of SEQ ID NOs: 127-133.

7. The cell of claim 1 , wherein the cell has a 23S rRNA sequence with at least 75% nucleotide identity to SEQ ID NO:15.

8. The cell of claim 1 , wherein the cell is Prototheca moriformis, Prototheca krugani, Prototheca stagnora or Prototheca zopfii.

9. The cell of claim 1 comprising an exogenous sucrose invertase gene and an exogenous fatty acyl-ACP thioesterase gene.

10. The cell of claim 1 , wherein the integration of the exogenous gene into the nuclear chromosome co-opts a host regulatory element or ablates an endogenous gene.

11. A cell of the genus Prototheca comprising an exogenous fatty acyl-ACP (acyl carrier protein) thioesterase gene and a lipid profile of at least 4% C8-C14, wherein the fatty acyl-ACP thioesterase gene encodes a fatty acyl-ACP thioesterase having a catalytic activity of hydrolyzing a fatty acyl-ACP substrate, and wherein the lipid profile has one or more of the following attributes:

(i) the amount of C8 is at least 0.3%;

(ii) the amount of C10 is at least 2%;

(iii) the amount of C12 is at least 2%; or

(iv) the amount of C14 is at least 4%.

12. The cell of claim 11 , wherein the amount of C8-C14 is at least 30%.

13. The cell of claim 11 , wherein the cell has a 23S rRNA sequence with at least 75% nucleotide identity to SEQ ID NO:15.

14. The cell of claim 11 , wherein the cell is Prototheca moriformis, Prototheca krugani, Prototheca stagnora or Prototheca zopfii.

15. The cell of claim 11 , wherein the exogenous fatty acyl-ACP thioesterase gene is integrated into a chromosome of the cell.

16. A method of making a triglyceride composition of at least 4% C8-C14 comprising cultivating the cell of claim 11 under heterotrophic conditions suitable for lipid production, thereby producing the triglyceride composition.

17. The method of claim 16 , wherein the amount of C8-C14 is at least 30%.

18. A method of making a triglyceride composition comprising cultivating the cell of claim 11 under heterotrophic conditions suitable for lipid production, thereby producing the triglyceride composition, wherein the cell further comprises an exogenous gene encoding a sucrose invertase and sucrose is provided as a carbon source.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2017
From: TERRAVIA HOLDINGS, INC.
To: CORBION BIOTECH, INC.
Reel/Frame 044424/0211 →
CHANGE OF NAME Recorded May 23, 2016
From: SOLAZYME, INC.
To: TERRAVIA HOLDINGS, INC.
Reel/Frame 038794/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2010
From: FRANKLIN, SCOTT; SOMANCHI, ARAVIND; ESPINA, KAREN; RUDENKO, GEORGE; CHUA, PENELOPE
To: SOLAZYME, INC.
Reel/Frame 023850/0554 →